-
Gestational diabetes (gdm) now complicates about one in 15 pregnancies, but, undoubtedly, the prevalence will increase even further if we cannot curb the concerning rise in obesity in this country.
-
You've seen her before. she's often young and partnered, but might be midlife and changing the status of her relationship. Sometimes she presents for an annual exam and mentions her pain later during the visit. Occasionally she actually presents with the complaint of dyspareunia.
-
The authors sought to estimate trends in prenatal drug exposure and neonatal abstinence syndrome (NAS) in Washington State from 2000 to 2008.
-
Is azithromycin proarrhythmic? Macrolide antibiotics are associated with an increased risk of sudden cardiac death, but azithromycin (Zithromax), the popular "Z pack" macrolide, has been considered safe.
-
-
The emergence of maternal DNA testing for fetal an-euploidies has necessitated a rethinking of our standard screening protocols. With reasonable accuracy, a single blood test can now rule out fetal trisomy 21, 18, and 13, in addition to sex chromosome abnormalities such as Turner syndrome.
-
Between September 1, 1987, and January 31, 2001, a total of 4047 obese persons were enrolled in the Swedish Obesity Study (SOS) intervention trial.
-
Mediators of the autonomic response to stress, such as the catecholamines norepinephrine and epinephrine, promote cancer growth, metastasis, and progression in preclinical models.
-
Although the incidence of hysterectomy has declined in recent years, it remains the most common major gynecologic procedure, and many women are offered or consider elective bilateral oophorectomy (BSO) at the time of hysterectomy to reduce ovarian cancer risk.
-
In this issue: Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.